The market of chiral drugs: Chiral switches versus de novo enantiomerically pure compounds.

Abstract

This review article is aimed at providing an overview of the current market of chiral drugs by exploring which is the nowadays tendency, for the pharmaceutical industry, either to exploit the chiral switching practice from already marketed racemates or to develop de novo enantiomerically pure compounds. A concise illustration of the main techniques… (More)
DOI: 10.1016/j.jpba.2017.07.008

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.